Larynx: Clinical Trials

1 trial for Larynx, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1

Follow Larynx: new trials by email Literature Review of Larynx trials Research Report on Larynx

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Window of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to Identify Immune Dynamics in Surgically Resectable Head and Neck Cancer Patients.
Durvalumab, durvalumab + tremelimumab - Stage II-IVB Operable HNSCC Oral Cavity, Hypopharynx
Phase 2UnknownYonsei University482019-01-022023-03-21

Narrower conditions

Laryngeal Diseases (1)

Broader conditions

Otorhinolaryngologic Diseases (1)  ·  Respiratory Tract Diseases (1)

Interventions

durvalumab (1)  ·  tremelimumab (1)

Sponsors

Yonsei University (1)

Countries

South Korea (1)

Results publications

PMID 38857913, PMID 41045934